Search Results - "Verleden, Geert"

A new classification system for chronic lung allograft dysfunction by Verleden, Geert M., MD, PhD, Raghu, Ganesh, PhD, Meyer, Keith C., PhD, Glanville, Allan R., MBBS, MD, FRACP, Corris, Paul, MBBS, FRCP

“…Although survival after lung transplantation has improved significantly during the last decade, chronic rejection is thought to be the major cause of late…”
Get full text

Survival in adult lung transplantation: where are we in 2020? by Bos, Saskia, Vos, Robin, Van Raemdonck, Dirk E., Verleden, Geert M.

“…In this article, an overview of the survival after lung transplantation will be given, with a focus on factors affecting outcome and differences in survival…”
Get full text

Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment―A consensus report from the Pulmonary Council of the ISHLT by Verleden, Geert M., Glanville, Allan R., Lease, Erika D., Fisher, Andrew J., Calabrese, Fiorella, Corris, Paul A., Ensor, Christopher R., Gottlieb, Jens, Hachem, Ramsey R., Lama, Vibha, Martinu, Tereza, Neil, Desley A.H., Singer, Lianne G., Snell, Greg, Vos, Robin

Get full text

A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation by Weill, David, MD, Benden, Christian, MD, Corris, Paul A., MD, Dark, John H., FRCS, Davis, R. Duane, MD, Keshavjee, Shaf, MD, Lederer, David J., MD, Mulligan, Michael J., MD, Patterson, G. Alexander, MD, Singer, Lianne G., MD, Snell, Greg I., MD, Verleden, Geert M., MD, PhD, Zamora, Martin R., MD, Glanville, Allan R., MBBS, MD

“…The appropriate selection of lung transplant recipients is an important determinant of outcomes. This consensus document is an update of the recipient…”
Get full text

Azithromycin: Mechanisms of action and their relevance for clinical applications by PARNHAM, Michael J, HABER, Vesna Erakovic, GIAMARELLOS-BOURBOULIS, Evangelos J, PERLETTI, Gianpaolo, VERLEDEN, Geert M, VOS, Robin

“…Azithromycin is a macrolide antibiotic which inhibits bacterial protein synthesis, quorum-sensing and reduces the formation of biofilm. Accumulating…”
Get full text

Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome―A consensus report from the Pulmonary Council of the ISHLT by Glanville, Allan R., Verleden, Geert M., Todd, Jamie L., Benden, Christian, Calabrese, Fiorella, Gottlieb, Jens, Hachem, Ramsey R., Levine, Deborah, Meloni, Federica, Palmer, Scott M., Roman, Antonio, Sato, Masaaki, Singer, Lianne G., Tokman, Sofya, Verleden, Stijn E., von der Thüsen, Jan, Vos, Robin, Snell, Gregory

Get full text

Advances in Understanding Bronchiolitis Obliterans After Lung Transplantation by Verleden, Stijn E., PhD, Sacreas, Annelore, MSc, Vos, Robin, MD, PhD, Vanaudenaerde, Bart M., PhD, Verleden, Geert M., MD, PhD

“…Bronchiolitis obliterans syndrome (BOS) remains a major complication after lung transplantation, causing significant morbidity and mortality in a majority of…”
Get full text

Lung transplantation for COPD/pulmonary emphysema by Verleden, Geert M, Gottlieb, Jens

“…COPD and α-1 antitrypsin deficiency emphysema remain one of the major indications for lung transplantation. If all other treatment possibilities are exhausted…”
Get full text

Disease progression in patients with the restrictive and mixed phenotype of Chronic Lung Allograft dysfunction-A retrospective analysis in five European centers to assess the feasibility of a therapeutic trial by Gottlieb, Jens, Verleden, Geert M, Perchl, Michael, Valtin, Christina, Vallee, Alexander, Brugière, Olivier, Bravo, Carlos

“…Chronic Lung Allograft Dysfunction (CLAD) is a major obstacle for long term survival after lung transplantation (LTx). Besides Bronchiolitis Obliterans…”
Get full text

Tracheal Allotransplantation after Withdrawal of Immunosuppressive Therapy by Delaere, Pierre, Vranckx, Jan, Verleden, Geert, De Leyn, Paul, Van Raemdonck, Dirk

“…A donor trachea, harvested from a cadaver, was transplanted into the forearm of a recipient and wrapped in the recipient's fascia. Months later, a vascular…”
Get full text

Nonpharmacological interventions in COPD by Janssens, Wim, Verleden, Geert M

“…COPD is recognised as one of the major health challenges for the coming decades. This is primarily driven by a growing burden of the disease due to persistent…”
Get full text

COVID‐19 in lung transplant patients: A case series by Verleden, Geert M., Godinas, Laurent, Lorent, Natalie, Van Bleyenbergh, Pascal, Dupont, Lieven, Delcroix, Marion, Yserbyt, Jonas, Dooms, Christophe, Vos, Robin

“…Several case reports and small case series have been published on coronavirus disease 2019 infection after solid organ transplantation; however, thus far there…”
Get full text

An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome by MEYER, Keith C, RAGHU, Ganesh, VERLEDEN, Geert M, CORRIS, Paul A, AURORA, Paul, WILSON, Kevin C, BROZEK, Jan, GLANVILLE, Allan R

“…Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that is associated with poor survival. The International Society for…”
Get full text

Commentary: Recipient-tailored segmental lung transplantation: First aid kit for kids in urgent need? by Van Raemdonck, Dirk, Ceulemans, Laurens J., Vos, Robin, Verleden, Geert M.

Get full text

Antifungal Prophylaxis After Lung Transplantation: Where Are We Now? by De Mol, Wim, Bos, Saskia, Beeckmans, Hanne, Lagrou, Katrien, Spriet, Isabel, Verleden, Geert M., Vos, Robin

“…Lung transplantation is an important treatment option for various end-stage lung diseases. However, survival remains limited due to graft rejection and…”
Get full text

Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation by Verleden, Stijn E, Vanaudenaerde, Bart M, Emonds, Marie-Paul, Van Raemdonck, Dirk E, Neyrinck, Arne P, Verleden, Geert M, Vos, Robin

“…Donor-specific antibodies (DSAs) against human leukocyte antigen (HLA) are associated with chronic lung allograft dysfunction (CLAD) and mortality post lung…”
Get full text

Commentary: How best to dance tango in lung transplantation for chronic obstructive pulmonary disease? by Van Raemdonck, Dirk, Ceulemans, Laurens J., Vos, Robin, Verleden, Geert M.

Get full text

The pathogenesis of pulmonary fibrosis: a moving target by WUYTS, Wim A, AGOSTINI, Carlo, PRASSE, Antje, ROBALO-CORDEIRO, Carlos, VERBEKEN, Eric, VERSCHAKELEN, Johny A, WELLS, Athol U, VERIEDEN, Geert M, ANTONIOU, Katerina M, BOUROS, Demosthenes, CHAMBERS, Rachel C, COTTIN, Vincent, EGAN, Jim J, LAMBRECHT, Bart N, LORIES, Rik, PARFREY, Helen

“…Pulmonary fibrosis is the end stage of many diffuse parenchymal lung diseases. It is characterised by excessive matrix formation leading to destruction of the…”
Get full text

Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation by Levine, Deborah J., Glanville, Allan R., Aboyoun, Christina, Belperio, John, Benden, Christian, Berry, Gerald J., Hachem, Ramsey, Hayes, Don, Neil, Desley, Reinsmoen, Nancy L., Snyder, Laurie D., Sweet, Stuart, Tyan, Dolly, Verleden, Geert, Westall, Glen, Yusen, Roger D., Zamora, Martin, Zeevi, Adriana

“…Antibody-mediated rejection (AMR) is a recognized cause of allograft dysfunction in lung transplant recipients. Unlike AMR in other solid-organ transplant…”
Get full text

Chronic lung allograft dysfunction phenotypes and treatment by Verleden, Stijn E, Vos, Robin, Vanaudenaerde, Bart M, Verleden, Geert M

“…Chronic lung allograft dysfunction (CLAD) remains a major hurdle limiting long-term survival post lung transplantation. Given the clinical heterogeneity of…”
Get full text